PROVO, UT, Canary Speech, a leading AI-powered voice biomarker health tech company, has secured a $13 million Series A funding.
Canary Speech, Inc. (Canary), the leading AI-powered voice biomarker health tech company, has secured a $13 million Series A funding round led by Cortes Capital, LLC (Love's Private Equity), with participation from Sorenson Communications, LLC., SMK (Japan), and Hackensack Meridian Health.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
